The potential impact of melanosomal pH and metabolism on melanoma.

cAMP melanin melanoma melanosome pH reactive oxygen (ROS)

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 02 03 2022
accepted: 08 08 2022
entrez: 9 12 2022
pubmed: 10 12 2022
medline: 10 12 2022
Statut: epublish

Résumé

Melanin is synthesized in melanocytes and is transferred into keratinocytes to block the effects of ultraviolet (UV) radiation and is important for preventing skin cancers including melanoma. However, it is known that after melanomagenesis and melanoma invasion or metastases, melanin synthesis still occurs. Since melanoma cells are no longer involved in the sun tanning process, it is unclear why melanocytes would maintain melanin synthesis after melanomagenesis has occurred. Aside from blocking UV-induced DNA mutation, melanin may provide other metabolic functions that could benefit melanoma. In addition, studies have suggested that there may be a selective advantage to melanin synthesis in melanoma; however, mechanisms regulating melanin synthesis outside the epidermis or hair follicle is unknown. We will discuss how melanosomal pH controls melanin synthesis in melanocytes and how melanosomal pH control of melanin synthesis might function in melanoma. We will also discuss potential reasons why melanin synthesis might be beneficial for melanoma cellular metabolism and provide a rationale for why melanin synthesis is not limited to benign melanocytes.

Identifiants

pubmed: 36483028
doi: 10.3389/fonc.2022.887770
pmc: PMC9723380
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

887770

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR077664
Pays : United States

Informations de copyright

Copyright © 2022 You, Yusupova and Zippin.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Physiol Rev. 2004 Oct;84(4):1155-228
pubmed: 15383650
J Phys Chem B. 2020 Mar 19;124(11):2110-2115
pubmed: 32105072
Sci Signal. 2018 Nov 06;11(555):
pubmed: 30401788
J Chem Ecol. 2005 Feb;31(2):237-46
pubmed: 15856781
Melanoma Res. 2013 Dec;23(6):452-60
pubmed: 24128789
Science. 2011 Dec 2;334(6060):1278-83
pubmed: 22052977
Int J Cosmet Sci. 2005 Jun;27(3):147-53
pubmed: 18492181
Pigment Cell Res. 2003 Oct;16(5):487-93
pubmed: 12950725
Pigment Cell Res. 2001 Feb;14(1):23-31
pubmed: 11277491
Arch Biochem Biophys. 2014 Dec 1;563:79-93
pubmed: 24997364
Mol Pharmacol. 1988 Apr;33(4):470-6
pubmed: 3357487
Trends Biochem Sci. 2014 Aug;39(8):347-54
pubmed: 25037503
Melanoma Res. 1992 Dec;2(5-6):305-14
pubmed: 1337997
Pigment Cell Melanoma Res. 2012 Jan;25(1):14-27
pubmed: 21834848
Nat Commun. 2018 May 8;9(1):1684
pubmed: 29739929
Annu Rev Biochem. 1976;45:559-604
pubmed: 9027
Nat Genet. 2008 Jul;40(7):835-7
pubmed: 18488028
J Invest Dermatol. 2001 Jul;117(1):158-9
pubmed: 11442766
Nature. 2009 May 28;459(7246):596-600
pubmed: 19387438
J Invest Dermatol. 1991 Aug;97(2):340-4
pubmed: 2071942
Elife. 2014 Dec 16;3:e04543
pubmed: 25513726
Biochem J. 1988 Jun 1;252(2):481-7
pubmed: 3137928
Neoplasma. 1991;38(4):393-400
pubmed: 1922572
Pigment Cell Res. 2003 Oct;16(5):523-31
pubmed: 12950732
Int J Cancer. 2009 Mar 15;124(6):1470-7
pubmed: 19085934
FASEB J. 2007 Apr;21(4):976-94
pubmed: 17242160
Pigment Cell Melanoma Res. 2017 May;30(3):372-377
pubmed: 28271633
Cold Spring Harb Symp Quant Biol. 2016;81:163-175
pubmed: 28082378
Photochem Photobiol. 2008 May-Jun;84(3):582-92
pubmed: 18435614
Elife. 2019 Mar 12;8:
pubmed: 30860481
Int J Mol Sci. 2018 Sep 23;19(10):
pubmed: 30249034
Oncotarget. 2016 Apr 5;7(14):17844-53
pubmed: 26910282
Pigment Cell Res. 1999 Feb;12(1):4-12
pubmed: 10193677
J Theor Biol. 1993 Sep 7;164(1):103-20
pubmed: 8264240
Pigment Cell Melanoma Res. 2021 Jul;34(4):730-747
pubmed: 33751833
Nature. 2012 Nov 15;491(7424):449-53
pubmed: 23123854
Science. 2017 Nov 17;358(6365):
pubmed: 29025994
Biomed Res Int. 2013;2013:908797
pubmed: 23555101
Cell. 2016 Aug 11;166(4):963-976
pubmed: 27477511
J Invest Dermatol. 1997 Dec;109(6):796-800
pubmed: 9406823
Exp Dermatol. 2015 Apr;24(4):258-9
pubmed: 25496715
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10964-9
pubmed: 16037214
Anticancer Res. 1998 Sep-Oct;18(5B):3709-15
pubmed: 9854482
PLoS Genet. 2021 Jan 19;17(1):e1009236
pubmed: 33465068
Nature. 2015 Nov 12;527(7577):186-91
pubmed: 26466563
Free Radic Biol Med. 1999 Mar;26(5-6):518-25
pubmed: 10218640
Nat Genet. 2015 Dec;47(12):1475-81
pubmed: 26482881
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8595-E8602
pubmed: 28923947
Science. 2006 Jun 30;312(5782):1882-3
pubmed: 16809515
FASEB J. 1990 Jun;4(9):2587-97
pubmed: 2189775
J Invest Dermatol. 2010 Feb;130(2):520-8
pubmed: 19710684
J Biol Chem. 2002 Dec 6;277(49):47399-406
pubmed: 12221084
Mol Biol Cell. 2020 Nov 15;31(24):2687-2702
pubmed: 32966160
Pigment Cell Melanoma Res. 2009 Oct;22(5):544-62
pubmed: 19619260
Photochem Photobiol. 2008 Mar-Apr;84(2):501-8
pubmed: 18282187
Acta Derm Venereol. 1994 Sep;74(5):375-9
pubmed: 7817676
Nature. 2009 Sep 3;461(7260):109-13
pubmed: 19693011
Pigment Cell Res. 1993 Oct;6(5):348-53
pubmed: 8302773
Biochim Biophys Acta. 1997 Oct 20;1336(3):539-48
pubmed: 9367182
J Invest Dermatol. 2021 Jul;141(7):1810-1818.e6
pubmed: 33549605
Biochim Biophys Acta Biomembr. 2020 Dec 1;1862(12):183318
pubmed: 32333855
Photochem Photobiol. 2008 May-Jun;84(3):539-49
pubmed: 18435612
Exp Cell Res. 2004 Aug 15;298(2):521-34
pubmed: 15265699
Hum Mutat. 2008 Sep;29(9):1161-7
pubmed: 18563784
Exp Dermatol. 2008 May;17(5):395-404
pubmed: 18177348
J Invest Dermatol. 2012 Sep;132(9):2255-62
pubmed: 22572817
J Theor Biol. 1990 Mar 8;143(1):123-38
pubmed: 2359315
Clin Transl Oncol. 2021 Sep;23(9):1874-1884
pubmed: 33811629
Sci Rep. 2016 May 27;6:26570
pubmed: 27231233
Pigment Cell Res. 1989 Mar-Apr;2(2):109-16
pubmed: 2497448
J Dermatol Sci. 2013 Jan;69(1):30-7
pubmed: 23103111
Front Oncol. 2022 Mar 14;12:842496
pubmed: 35359389
Nature. 2020 Dec;588(7839):699-704
pubmed: 33208952
Pflugers Arch. 2009 Sep;458(5):891-9
pubmed: 19557428
Pigment Cell Melanoma Res. 2013 Nov;26(6):817-25
pubmed: 23844795
Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1789-93
pubmed: 7878059
Endocrinology. 2018 May 1;159(5):1992-2007
pubmed: 29546369
Exp Cell Res. 2001 Aug 1;268(1):26-35
pubmed: 11461115
Arch Biochem Biophys. 2014 Dec 1;563:35-41
pubmed: 25034214
Proc Natl Acad Sci U S A. 2016 May 17;113(20):5622-7
pubmed: 27140606
Adv Exp Med Biol. 2017;996:15-23
pubmed: 29124687
J Invest Dermatol. 1996 Nov;107(5):698-702
pubmed: 8875952
Nat Commun. 2019 Jan 21;10(1):358
pubmed: 30664655
Oncogene. 2021 Mar;40(10):1792-1805
pubmed: 33564068
Hum Pathol. 2013 Oct;44(10):2071-4
pubmed: 23791398

Auteurs

Jaewon You (J)

Department of Dermatology, Weill Cornell Medical College of Cornell University, New York, NY, United States.

Maftuna Yusupova (M)

Department of Dermatology, Weill Cornell Medical College of Cornell University, New York, NY, United States.

Jonathan H Zippin (JH)

Department of Dermatology, Weill Cornell Medical College of Cornell University, New York, NY, United States.

Classifications MeSH